Skip to main content

Advertisement

SpringerLink
Log in

Aggression in Borderline Personality Disorder

  • Original Paper
  • Published:
Psychiatric Quarterly Aims and scope Submit manuscript

Abstract

This review examined aggressive behavior in Borderline Personality Disorder (BPD) and its management in adults. Aggression against self or against others is a core component of BPD. Impulsiveness is a clinical hallmark (as well as a DSM-IV-TR diagnostic criterion) of BPD, and aggressive acts by BPD patients are largely of the impulsive type. BPD has high comorbidity rates with substance use disorders, Bipolar Disorder, and Antisocial Personality Disorder; these conditions further elevate the risk for violence. Treatment of BDP includes psychodynamic, cognitive behavioral, schema therapy, dialectic behavioral, group and pharmacological interventions. Recent studies indicate that many medications, particularly atypical antipsychotics and anticonvulsants, may reduce impulsivity, affective lability as well as irritability and aggressive behavior. But there is still a lack of large, double blind, placebo controlled studies in this area.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Oquendo MA, Mann JJ: The biology of impulsivity and suicidality. Psychiatric Clinics of North America 23:11–25, 2000.

    Article  CAS  PubMed  Google Scholar 

  2. Moyer KE: The Psychobiology of Aggression. New York, Harper & Row Publishers, 1976.

    Google Scholar 

  3. Citrome L, Volavka J: Treatment of Violent Behavior. In: Tasman A, Kay J, Lieberman JA (Eds) Psychiatry, 2 edn. Chichester, John Wiley & Sons Ltd, 2003.

    Google Scholar 

  4. Soloff PH, Meltzer CC, Becker C, et al.: Impulsivity and prefrontal hypometabolism in borderline personality disorder. Psychiatry Research: Neuroimaging Section 123:153–163, 2003.

    Article  CAS  Google Scholar 

  5. Coccaro EF, Harvey PD, Kupsaw-Lawrence E, et al.: Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior. Journal of Neuropsychiatry and Clinical Neurosciences 3:S44–S51, 1991.

    CAS  PubMed  Google Scholar 

  6. Arntz A, van den HM, Cornelis J, et al.: Reliability and validity of the borderline personality disorder severity index. Journal of Personality Disorders 17:45–59, 2003.

  7. Buss AH, Durkee A: An inventory for assessing different kinds of hostility. Journal of Consulting Psychology 21:343–349, 1957.

    Article  CAS  PubMed  Google Scholar 

  8. Schwenkenmezger P, Hodapp V, Spielberger CD: The State-Trait Anger Expression Inventory. Goettingen, Huber, 1992.

    Google Scholar 

  9. Buss AH, Perry M: The aggression questionnaire. Journal of Personality and Social Psychology 63:452–459, 1992.

    Article  CAS  PubMed  Google Scholar 

  10. Swanson JW, Holzer CE, Ganju VK, et al.: Violence and psychiatric disorder in the community: evidence from the epidemiologic catchment area surveys. Hospital and Community Psychiatry 41:761–770, 1990.

    CAS  Google Scholar 

  11. Pulay AJ, Dawson DA, Hasin DS, et al.: Violent behavior and DSM-IV psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions. Journal of Clinical Psychiatry e1–e11, 2007.

  12. Fazel S, Gulati G, Linsell L, et al.: Schizophrenia and violence: systematic review and meta-analysis. PLoS Medicine 6:e1000120, 2009.

    Google Scholar 

  13. Fountoulakis KN, Leucht S, Kaprinis GS: Personality disorders and violence. Current Opinion in Psychiatry 21:84–92, 2008.

    Article  PubMed  Google Scholar 

  14. Grant BF, Chou SP, Goldstein RB, et al.: Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions. Journal of Clinical Psychiatry 69:533–545, 2008.

    Article  PubMed  Google Scholar 

  15. Zanarini MC, Frankenburg FR, Reich DB, et al.: Violence in the lives of adult borderline patients. Journal of Nervous and Mental Disease 187:65–71, 1999.

    Article  CAS  PubMed  Google Scholar 

  16. Goodman M, New A: Impulsive aggression in borderline personality disorder. Current Psychiatry Reports 2:56–61, 2000.

    Article  CAS  PubMed  Google Scholar 

  17. de Barros DM, de Padua SA: Association between personality disorder and violent behavior pattern. Forensic Science International 179:19–22, 2008.

    Article  PubMed  Google Scholar 

  18. Nickel MK, Nickel C, Mitterlehner FO, et al.: Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study. Journal of Clinical Psychiatry 65:1515–1519, 2004.

    Article  CAS  PubMed  Google Scholar 

  19. Raine A: Features of borderline personality and violence. Journal of Clinical Psychology 49:277–281, 1993.

    Article  CAS  PubMed  Google Scholar 

  20. Swartz MS, Swanson JW, Hiday VA, et al.: Violence and severe mental illness: the effects of substance abuse and nonadherence to medication. American Journal of Psychiatry 155:226–231, 1998.

    CAS  PubMed  Google Scholar 

  21. Latalova K: Bipolar disorder and aggression. International Journal of Clinical Practice 63:889–899, 2009.

    Article  CAS  PubMed  Google Scholar 

  22. Coid J, Yang M, Roberts A, et al.: Violence and psychiatric morbidity in the national household population of Britain: public health implications. British Journal of Psychiatry 189:12–19, 2006.

    Article  PubMed  Google Scholar 

  23. Howard RC, Huband N, Duggan C, et al.: Exploring the link between personality disorder and criminality in a community sample. Journal of Personality Disorders 22:589–603, 2008.

    Article  PubMed  Google Scholar 

  24. Elbogen EB, Johnson SC: The intricate link between violence and mental disorder: results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry 66:152–161, 2009.

    Article  PubMed  Google Scholar 

  25. Soloff PH, George A, Nathan RS, et al.: Progress in pharmacotherapy of borderline disorders. A double- blind study of amitriptyline, haloperidol, and placebo. Archives of General Psychiatry 43:691–697, 1986.

    CAS  Google Scholar 

  26. Soloff PH, Cornelius J, George A, et al.: Efficacy of phenelzine and haloperidol in borderline personality disorder. Archives of General Psychiatry 50:377–385, 1993.

    CAS  PubMed  Google Scholar 

  27. Simpson EB, Yen S, Costello E, et al.: Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder. Journal of Clinical Psychiatry 65:379–385, 2004.

    Article  CAS  PubMed  Google Scholar 

  28. Rinne T, van den BW, Wouters L, et al.: SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. American Journal of Psychiatry 159:2048–2054, 2002.

  29. Nickel MK, Muehlbacher M, Nickel C, et al.: Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study. American Journal of Psychiatry 163:833–838, 2006.

    Article  PubMed  Google Scholar 

  30. Soler J, Pascual JC, Campins J, et al.: Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder. American Journal of Psychiatry 162:1221–1224, 2005.

    Article  PubMed  Google Scholar 

  31. Pascual JC, Oller S, Soler J, et al.: Ziprasidone in the acute treatment of borderline personality disorder in psychiatric emergency services. Journal of Clinical Psychiatry 65:1281–1282, 2004.

    Article  PubMed  Google Scholar 

  32. Bellino S, Paradiso E, Bogetto F: Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study. Journal of Clinical Psychiatry 67:1042–1046, 2006.

    Article  CAS  PubMed  Google Scholar 

  33. Perrella C, Carrus D, Costa E, et al.: Quetiapine for the treatment of borderline personality disorder; an open-label study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31:158–163, 2007.

    Article  CAS  PubMed  Google Scholar 

  34. Van den Eynde F, Senturk V, Naudts K, et al.: Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder. Journal of Clinical Psychopharmacology 28:147–155, 2008.

    Article  PubMed  Google Scholar 

  35. Chengappa KN, Ebeling T, Kang JS, et al.: Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. Journal of Clinical Psychiatry 60:477–484, 1999.

    CAS  PubMed  Google Scholar 

  36. Rocca P, Marchiaro L, Cocuzza E, et al.: Treatment of borderline personality disorder with risperidone. Journal of Clinical Psychiatry 63:241–244, 2002.

    CAS  PubMed  Google Scholar 

  37. Tritt K, Nickel C, Lahmann C, et al.: Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study. Journal of Psychopharmacology 19:287–291, 2005.

    Article  CAS  PubMed  Google Scholar 

  38. Nickel MK, Nickel C, Kaplan P, et al.: Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study. Biological Psychiatry 57:495–499, 2005.

    Article  CAS  PubMed  Google Scholar 

  39. Frankenburg FR, Zanarini MC: Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study. Journal of Clinical Psychiatry 63:442–446, 2002.

    CAS  PubMed  Google Scholar 

  40. Simeon D, Baker B, Chaplin W, et al.: An open-label trial of divalproex extended-release in the treatment of borderline personality disorder. CNS Spectrums 12:439–443, 2007.

    PubMed  Google Scholar 

  41. Zanarini MC, Frankenburg FR: Omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. American Journal of Psychiatry 160:167–169, 2003.

    Article  PubMed  Google Scholar 

  42. Links PS, Heslegrave R, Villella J: Psychopharmacological management of personality disorders: an outcome focused model. In: Silk KR (Ed) Biology of personality disorders. Washington, DC, American Psychiatric Press, pp. 93–127, 1998.

    Google Scholar 

  43. Soloff PH: Algorithm for pharmacological treatment of personality dimensions: symptom-specific treatments for cognitive-perceptual, affective and impulsive-behavioral dysregulation. Bulletin of the Menninger Clinic 62:195–214, 1998.

    CAS  PubMed  Google Scholar 

  44. Stevenson J, Meares R: An outcome study of psychotherapy for patients with borderline personality disorder. American Journal of Psychiatry 149:358–362, 1992.

    CAS  PubMed  Google Scholar 

  45. Meares R, Stevenson J, Comerford A: Psychotherapy with borderline patients, I: a comparison between treated and untreated cohorts. Australian and New Zealand Journal of Psychiatry 33:467–472, 1999.

    CAS  PubMed  Google Scholar 

  46. Clarkin JF, Foelsch P, Levy KN et al.: The development of a psychodynamic treatment for patients with borderline personality disorder: a preliminary study of behavioural change. The Journal of Personality Disorders 15:487–495, 2001.

    Article  CAS  Google Scholar 

  47. Bateman A, Fonagy P: The effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. American Journal of Psychiatry 156:1563–1569, 1999.

    CAS  PubMed  Google Scholar 

  48. Bateman A, Fonagy P: Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-months follow up. American Journal of Psychiatry 158:36–42, 2001.

    Article  CAS  PubMed  Google Scholar 

  49. Beck AT, Freeman AM: Cognitive therapy of personality disorders. New York, Guilford, 1990.

    Google Scholar 

  50. Davidson KA, Tyrer P: Cognitive therapy for antisocial and borderline personality disorders: single case study series. British Journal of Clinical Psychology 35:413–429, 1996.

    PubMed  Google Scholar 

  51. Tyrer P, Tom B, Byford S, et al.: Differential effects of manual assisted cognitive behaviour therapy in the treatment of recurrent deliberate self-harm and personality disturbance: the POPMACT study. The Journal of Personality Disorders 4:161–172, 2004.

    Google Scholar 

  52. Davidson K, Norrie JA, Tyrer P: The effectiveness of cognitive behavioral therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (BOSCOT) trial. The Journal of Personality Disorders 20:450–465, 2006.

    Article  Google Scholar 

  53. Linehan MM: Cognitive-Behavioral Treatment of Borderline Personality Disorder. New York, Guilford, 1993.

    Google Scholar 

  54. Linehan MM, Armstrong HE, Suarez A, Allmon D, Heard HL: Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Archives of General Psychiatry 48:1060–1064, 1991.

    CAS  PubMed  Google Scholar 

  55. Linehan MM, Tutek DA, Heard HL, Armstrong HE: Interpersonal outcome of cognitive behavioral treatment for chronically suicidal borderline patients. American Journal of Psychiatry 151:1771–1776, 1994.

    CAS  PubMed  Google Scholar 

  56. Linehan MM, Schmidt H III, Dimeff LA, Craft JC, Kanter J, Comtois KA: Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. American Journal on Addictions 8:279–292, 1999.

    Article  CAS  PubMed  Google Scholar 

  57. Linehan MM, Heard HL, Armstrong HE: Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients. Archives of General Psychiatry 50:971–974, 1993.

    CAS  PubMed  Google Scholar 

  58. Linehan MM, Comtois KA, Murray AM, Brown MZ, Gallop RJ, Heard HL, Korslund KE, Tutek DA, Reynolds SK, Lindenboim N: Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Archives of General Psychiatry. 63:757–766, 2006.

    Article  PubMed  Google Scholar 

  59. Binks CA, Fenton M, McCarthy L et al.: Pharmacological interventions for people with borderline personality disorder. Cochrane Database of Systematic Reviews 1:CD005653, 2006.

  60. Nose M, Cipriani A, Biancosino B et al.: Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials. International Clinical Psychopharmacology 21:345–353, 2006.

    Article  PubMed  Google Scholar 

  61. Herpertz SC, Zanarini M, Schulz CS et al.: World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of personality disorders. World Journal of Biological Psychiatry 8:212–244, 2007.

    Article  PubMed  Google Scholar 

  62. Soloff PH, George A, Nathan RS, et al.: Paradoxical effects of amitriptyline on borderline patients. American Journal of Psychiatry 143:1603–1605, 1986.

    CAS  PubMed  Google Scholar 

  63. Soloff PH, George A, Nathan RS, et al.: Behavioral dyscontrol in borderline patients treated with amitriptyline. Psychopharmacology Bulletin 23:177–181, 1987.

    CAS  PubMed  Google Scholar 

  64. Linehan MM, McDavid JD, Brown MZ, et al.: Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: a double-blind, placebo-controlled pilot study. Journal of Clinical Psychiatry 69:999–1005, 2008.

    Article  CAS  PubMed  Google Scholar 

  65. Pascual JC, Soler J, Puigdemont D, et al.: Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study. Journal of Clinical Psychiatry 69:603–608, 2008.

    Article  CAS  PubMed  Google Scholar 

  66. Lipman RS, Covi L, Shapiro AK: The Hopkins symptom checklist (HSCL)––factors derived from the HSCL-90. Journal of Affective Disorders 1:9–24, 1979.

    Article  CAS  PubMed  Google Scholar 

  67. Teicher MH, Glod CA, Aaronson ST, et al.: Open assessment of the safety and efficacy of thioridazine in the treatment of patients with borderline personality disorder. Psychopharmacology Bulletin 25:535–549, 1989.

    CAS  PubMed  Google Scholar 

  68. Hollander E, Allen A, Lopez RP, et al.: A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. Journal of Clinical Psychiatry 62:199–203, 2001.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic

    K. Látalová & J. Praško

Authors
  1. K. Látalová
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Praško
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Látalová.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Látalová, K., Praško, J. Aggression in Borderline Personality Disorder. Psychiatr Q 81, 239–251 (2010). https://doi.org/10.1007/s11126-010-9133-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11126-010-9133-3

Keywords

Search

Navigation